In cancer, anti-VEGF therapy is effective on a subset of metastatic tumours but overall has shown modest results than predicted, failing to show significant effects in advanced-stage tumours and being effective mainly when combined with chemotherapy [90,91]. The gene discussed is VEGFA; the disease is neoplasm.